Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia von Barsam, Sarah J., Psaila, Bethan, Forestier, Marc, Page, Lemke K., Sloane, Peter A., Geyer, Julia T., Villarica, Glynis O., Ruisi, Mary M., Gernsheimer, Terry B., Beer, Juerg H., Bussel, James B.

Volltext

Stability of measurement of the immature platelet fraction von Ruisi, Mary M., Psaila, Bethan, Ward, Mary J., Villarica, Glynnis, Bussel, James B.

Volltext

A phase 1/2 study of CFT1946, a novel, bifunctional degradation activating compound (BIDAC) degrader, of mutant BRAF V600 as monotherapy and in combination with trametinib, in muta... von McKean, Meredith, Spira, Alexander I., Rosen, Ezra, Subbiah, Vivek, Moreno, Victor, Gambardella, Valentina, Vieito, Maria, Saavedra, Omar, Cousin, Sophie, Cassier, Philippe Alexandre, Lobbardi, Riadh, Schönborn-Kellenberger, Oliver, Hurh, Eunju, Ruisi, Mary M., Buchbinder, Elizabeth Iannotti

Volltext

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial von Weber, Jeffrey S, Prof, Gibney, Geoff, MD, Sullivan, Ryan J, MD, Sosman, Jeffrey A, Prof, Slingluff, Craig L, Prof, Lawrence, Donald P, MD, Logan, Theodore F, MD, Schuchter, Lynn M, Prof, Nair, Suresh, MD, Fecher, Leslie, MD, Buchbinder, Elizabeth I, MD, Berghorn, Elmer, BSN, Ruisi, Mary, MD, Kong, George, PhD, Jiang, Joel, PhD, Horak, Christine, PhD, Hodi, F Stephen, Dr

Volltext

Digital pathology to evaluate PD-L1 IHC scoring as a predictor of outcome with second-line avelumab treatment in patients with non-small cell lung cancer (NSCLC) von Mrowiec, Thomas, Svenson, Elena, Gerhold-Ay, Aslihan, Wolf, Corinna M, Grote, Hans Juergen, Otte, Marcus, Rolfe, P. Alexander, Shah, Parantu K., von Heydebreck, Anja, Scheuenpflug, Juergen, Ruisi, Mary M., Labarta-Beceiro, Violeta, Beeman, Glenn, Cai, Ti

Volltext

Avelumab (anti–PD-L1) in patients with platinum-treated advanced NSCLC: 2.5-year follow-up from the JAVELIN Solid Tumor trial von Rajan, Arun, Gulley, James L., Spigel, David R., Iannotti, Nicholas, Chandler, Jason Claud, Wong, Deborah J.L., Leach, Joseph W., Edenfield, William Jeffery, Wang, Ding, Redfern, Charles H., Grote, Hans Juergen, von Heydebreck, Anja, Ruisi, Mary M., Munshi, Neru, Kelly, Karen

Volltext

A phase 2 study of a nivolumab (nivo)-containing regimen in patients (pts) with newly diagnosed classical Hodgkin lymphoma (cHL): Study 205 Cohort D von Armand, Philippe, Shipp, Margaret Ann, Kuruvilla, John, Collins, Graham P, Ramchandren, Rod, Timmerman, John, Sumbul, Anne, Ruisi, Mary M., Kato, Kazunobu, Ansell, Stephen Maxted

Volltext

Radioulnar Synostosis-Hematology (RUS-H) Syndrome: Description of the New Syndrome and Comparison to Similar Syndromes von Jessie, Evangelista E, Ruisi, Mary M., Green, Daniel, Burt, Rachel, Davis, Jaclyn, Macatangay, Regina A., Boulad, Farid, Shah, Shivani, Oiyemhonlan, Brenda, Kile, Benjamin T., Bussel, James B

Volltext

Radioulnar Synostosis and Its Hematology and Genetic Associations von Ruisi, Mary M., Jessica, Evangelista, Green, Daniel, Oiyemhonlan, Brenda, Shah, Shivani, Kile, Benjamin T, Burt, Rachel, Thompson, Alexis, Bussel, James B.

Volltext

A Phase III study at high risk for recurrence von Weber, Jeffrey, Grob, Jean-Jaques, Margolin, Kim A, Ascierto, Paolo A, Sznol, Mario, Ott, Patrick A, Lejeune, Chantal, de Pril, Veerle, Ruisi, Mary M, Hodi, F Stephen

Volltext

A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in pat... von Weber, Jeffrey, Grob, Jean-Jaques, Margolin, Kim A, Ascierto, Paolo A, Sznol, Mario, Ott, Patrick A, Lejeune, Chantal, de Pril, Veerle, Ruisi, Mary M, Hodi, F Stephen

Volltext

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial von Louie, Thomas, Golan, Yoav, Khanna, Sahil, Bobilev, Dmitri, Erpelding, Nathalie, Fratazzi, Candida, Carini, Meg, Menon, Rajita, Ruisi, Mary, Norman, Jason M, Faith, Jeremiah J, Olle, Bernat, Li, Minran, Silber, Jeffrey L, Pardi, Darrell S

Volltext

Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes von De Assuncao, Thiago M, Sun, Yan, Jalan-Sakrikar, Nidhi, Drinane, Mary C, Huang, Bing Q, Li, Ying, Davila, Jaime I, Wang, Ruisi, O'Hara, Steven P, Lomberk, Gwen A, Urrutia, Raul A, Ikeda, Yasuhiro, Huebert, Robert C

Volltext

890: RAPID AND DURABLE COLONIZATION OF VE303 IN CLOSTRIDIODES DIFFICILE INFECTION (CDI) PATIENTS IS ASSOCIATED WITH CLINICAL EFFICACY: RESULTS OF THE PHASE 2 CONSORTIUM STUDY von Menon, Rajita, Crossette, Emily M., Bhattarai, Shakti, Bucci, Vanni, Faith, Jeremiah, Ruisi, Mary, Olle, Bernat, Silber, Jeffrey L., Norman, Jason

Volltext

Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay von Grote, Hans Juergen, Feng, Zheng, Schlichting, Michael, Helwig, Christoph, Ruisi, Mary, Jin, Hulin, Scheuenpflug, Juergen, Gann, Claudia-Nanette, Su, Zhen, Reck, Martin, Vokes, Everett E., Kerr, Keith M.

Volltext

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial von Loeb, David M., Lee, Ji Won, Morgenstern, Daniel A., Samson, Yvan, Uyttebroeck, Anne, Lyu, Chuhl Joo, Van Damme, An, Nysom, Karsten, Macy, Margaret E., Zorzi, Alexandra P., Xiong, Julia, Pollert, Petra, Joerg, Ingrid, Vugmeyster, Yulia, Ruisi, Mary, Kang, Hyoung Jin

Volltext

Abstract 2725: Galectin-9 drives TIM-3 mediated immune suppression von Deshpande, Amit M., Fontana, Rachel, Zhang, Yue, Ruisi, Mary, Zhang, Dong, Senger, Tilo, Rolfe, P. Alexander

Volltext

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial von Loeb, David M, Lee, Ji Won, Morgenstern, Daniel A, Samson, Yvan, Uyttebroeck, Anne, Lyu, Chuhl Joo, Van Damme, An, Nysom, Karsten, Macy, Margaret E, Zorzi, Alexandra P, Xiong, Julia, Pollert, Petra, Joerg, Ingrid, Vugmeyster, Yulia, Ruisi, Mary, Kang, Hyoung Jin

Volltext

Erratum: Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes von De Assuncao, Thiago M, Sun, Yan, Jalan-Sakrikar, Nidhi, Drinane, Mary C, Huang, Bing Q, Li, Ying, Davila, Jaime I, Wang, Ruisi, O'Hara, Steven P, Lomberk, Gwen A, Urrutia, Raul A, Ikeda, Yasuhiro, Huebert, Robert C

Volltext

Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes von De Assuncao, Thiago M, Sun, Yan, Jalan-Sakrikar, Nidhi, Drinane, Mary C, Huang, Bing Q, Li, Ying, Davila, Jaime I, Wang, Ruisi, O'Hara, Steven P, Lomberk, Gwen A, Urrutia, Raul A, Ikeda, Yasuhiro, Huebert, Robert C

Volltext